Investing.com - Marchex (NASDAQ: MCHX) reported second quarter EPS of $-0.010, $0.01 better than the analyst estimate of $-0.020. Revenue for the quarter came in at $12.1M versus the consensus estimate of $12.15M.
Guidance
Marchex sees Q3 2024 revenue of $12.600M versus the analyst consensus of $12.690M.
Marchex's stock price closed at $1.87. It is up 48.410% in the last 3 months and down -1.580% in the last 12 months.
Marchex saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Marchex's stock price’s past reactions to earnings here.
According to InvestingPro, Marchex's Financial Health score is "fair performance".
Check out Marchex's recent earnings performance, and Marchex's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar